Insights into the mode of action of the two-peptide lantibiotic haloduracin
about
High-resolution crystal structure reveals molecular details of target recognition by bacitracinThe high resolution structure of tyrocidine A reveals an amphipathic dimerPlantazolicin, a novel microcin B17/streptolysin S-like natural product from Bacillus amyloliquefaciens FZB42.Production of lantipeptides in Escherichia coli.Antibiotic discovery in the twenty-first century: current trends and future perspectives.Production of haloduracin by Bacillus halodurans using solid-state fermentation.Investigating the importance of charged residues in lantibiotics.Fermentation stage-dependent adaptations of Bacillus licheniformis during enzyme production.Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin.Haloduracin α binds the peptidoglycan precursor lipid II with 2:1 stoichiometryMichael-type cyclizations in lantibiotic biosynthesis are reversible.A gene network engineering platform for lactic acid bacteria.Chemical synthesis and biological activity of analogues of the lantibiotic epilancin 15X.Non-proteinogenic amino acids in lacticin 481 analogues result in more potent inhibition of peptidoglycan transglycosylation.The sequence of the enterococcal cytolysin imparts unusual lanthionine stereochemistry.Structural Characterization and Bioactivity Analysis of the Two-Component Lantibiotic Flv System from a Ruminant Bacterium.Discovery and Characterization of Bicereucin, an Unusual d-Amino Acid-Containing Mixed Two-Component Lantibiotic.Efficacy of Lantibiotic Treatment of Staphylococcus aureus-Induced Skin Infections, Monitored by In Vivo Bioluminescent Imaging.Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive PathogensA general method for fluorescent labeling of the N-termini of lanthipeptides and its application to visualize their cellular localization.Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activityMode of action and structure-activity relationship studies of geobacillin I.Diversity and applications of Bacillus bacteriocins.Fundamental functionality: recent developments in understanding the structure-activity relationships of lantibiotic peptides.The dawning of a 'Golden era' in lantibiotic bioengineering.Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application.Contribution of the Actinobacteria to the growing diversity of lantibiotics.Anti-infective properties of bacteriocins: an update.Antimicrobial mechanism of lantibiotics.Peptide antimicrobials: cell wall as a bacterial target.Multipronged approach for engineering novel peptide analogues of existing lantibiotics.Easy and rapid purification of highly active nisin.Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.Cell Wall-active Bacteriocins and Their Applications Beyond Antibiotic Activity.Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly.Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.Targeting a cell wall biosynthesis hot spot.Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria.Towards Biocontained Cell Factories: An Evolutionarily Adapted Escherichia coli Strain Produces a New-to-nature Bioactive Lantibiotic Containing Thienopyrrole-Alanine.Lichenicidin biosynthesis in Escherichia coli: licFGEHI immunity genes are not essential for lantibiotic production or self-protection.
P2860
Q27679545-32E25513-77EF-4469-8C03-44F4AE674095Q27681739-88AFA86D-91C1-493A-9BC3-1A0843BC7CBFQ33726775-4A4B506E-F952-4EAA-9FC6-B924EFB4EACAQ33757676-3604CD4F-058D-4841-813A-3DD7F38ED9F9Q34121033-D0D2F011-03CD-45C3-A8D2-CB2185915B86Q34169175-9DD3DDEB-C7EE-4FAB-A11C-FE6E0706BF7DQ34568188-A77BD36C-CEF9-41C8-B83E-C0F04AEC3BF0Q35061801-3F4BAA48-D550-4DC8-BECF-C7301D4C0875Q35227109-AE3A9950-4616-4C05-8D57-7A20E9579147Q35505448-FBD7CFF3-7D05-499A-BE06-748E335E5626Q35568811-DAEBB6BC-A0DD-419F-AAA6-33ED6FCF1483Q35821933-DAD09C38-91AE-47DB-9262-9DEA9B9D53C2Q35949915-E33B5CF0-5F10-483C-8EFA-9291A3D2C98FQ36408239-5BCFD9DD-DBD3-446A-87BA-7033A87E78BAQ36625577-A146ECE4-8C62-49CE-90C9-8ACD16CC0AA3Q36748438-17A7B7FB-E9BC-41FF-B866-39FA1C905B7AQ36852046-644CE2D5-9826-4BEE-BAE0-0AC506417E9EQ37023281-65A0A02B-D935-4D45-9265-309438CF80CBQ37106265-698FA5FA-28A2-4DE6-BFA5-8C6C50529C72Q37177787-23BD9937-A759-48BB-BCB3-E7A1EAB52B39Q37712931-33FEE652-6183-4F0F-95DB-61C8166DB0E3Q37732541-18E2AFB3-78DB-4975-BF38-E6FDF01D130FQ37778851-04D50344-09EB-46C5-A2C8-C2A23420A645Q37809967-C3E1A21D-7368-4D58-8691-DA9F8C2FB4B7Q37811027-539605A2-47E4-40CE-869B-EB007849F33AQ38014580-D8BD4080-802E-4AD4-B9F7-EC031D8BA2D5Q38038546-DD92FCF0-9F75-45D4-808D-435D546564AEQ38056436-C81BEC1F-A009-4D17-A613-21F09594A198Q38062007-E73E8A4F-7359-4A85-979F-81810DDF1767Q38072770-B7F4F795-9E89-4038-A599-C2F86B251764Q38500614-9B825B56-9AC7-4890-BF5D-B9B5A120889EQ38509438-DC0E91FE-6F5A-42F6-944F-7E546D6E2F74Q38701785-21C033AF-6325-4A7A-ABD3-A24A2C26FEE1Q38702083-225B0125-439D-491D-B7D3-729574C39187Q39021205-DA31D4CF-3A52-4B0F-AE78-87885BB90500Q39109460-7C46D576-67C5-4F61-B9F0-3EF7DB4E4BB7Q39413308-C9BA3555-44CF-4992-845E-A83538E34FA6Q40274392-C27D6136-20EC-4B62-A9D9-4584978DABB0Q41107514-8BA58F7D-0932-49CC-8EF5-B5AEC8409411Q42115924-691AF1B3-763D-4183-B971-B7F5E06E5207
P2860
Insights into the mode of action of the two-peptide lantibiotic haloduracin
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Insights into the mode of action of the two-peptide lantibiotic haloduracin
@ast
Insights into the mode of action of the two-peptide lantibiotic haloduracin
@en
type
label
Insights into the mode of action of the two-peptide lantibiotic haloduracin
@ast
Insights into the mode of action of the two-peptide lantibiotic haloduracin
@en
prefLabel
Insights into the mode of action of the two-peptide lantibiotic haloduracin
@ast
Insights into the mode of action of the two-peptide lantibiotic haloduracin
@en
P2860
P356
P1433
P1476
Insights into the mode of action of the two-peptide lantibiotic haloduracin
@en
P2093
Trent J Oman
Wilfred A van der Donk
P2860
P304
P356
10.1021/CB900194X
P577
2009-10-01T00:00:00Z